Ultrastructural localization of intravenously injected carbon nanohorns in tumor

International Journal of Nanomedicine

Volumn 9, Issue 1, 2014, Pages 3499-3508

  Matsumura, Sachiko ^a   Yuge, Ryota ^b   Sato, Shigeo ^c   Tomida, Akihiro ^c   Ichihashi, Toshinari ^b   Irie, Hiroshi ^d   Iijima, Sumio ^b,e,f   Shiba, Kiyotaka ^a   Yudasaka, Masako ^f  

^a CANCER INSTITUTE   (Japan)

^b NEC CORPORATION   (Japan)

^c CANCER CHEMOTHERAPY CENTER   (Japan)

^d TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e MEIJO UNIVERSITY   (Japan)

^f NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

Author keywords

Carbon nanohorn; Extravasation; In vivo; Tumor; Ultrastructural localization

Indexed keywords

CARBON NANOHORN; MACROGOL; NANOHORN; PHOSPHOLIPID; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; CARBON NANOTUBE; MACROGOL DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; BLOOD VESSEL WALL; CONTROLLED STUDY; DERMIS; ENDOTHELIUM CELL; EXTRAVASATION; FEMALE; MACROPHAGE; MOUSE; NEOPLASM; NONHUMAN; SUBCUTANEOUS TISSUE; TISSUE DISTRIBUTION; TUMOR VASCULARIZATION; ULTRASTRUCTURE; ANIMAL; BAGG ALBINO MOUSE; CHEMISTRY; DRUG SCREENING; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; NUDE MOUSE; SKIN;

ANIMALS; ANTINEOPLASTIC AGENTS; INJECTIONS, INTRAVENOUS; MICE; MICE, INBRED BALB C; MICE, NUDE; NANOTUBES, CARBON; NEOPLASMS; PHOSPHOLIPIDS; POLYETHYLENE GLYCOLS; SKIN; TISSUE DISTRIBUTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84905018247     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S62688     Document Type: Article

References (31)

1. Robinson JT, Hong G, Liang Y, Zhang B, Yaghi OK, Dai H. In vivo fluorescence imaging in the second near-infrared window with long circulating carbon nanotubes capable of ultrahigh tumor uptake. J Am Chem Soc. 2012; 134(25): 10664-10669.
2. Liu Z, Chen K, Davis C, et al. Drug delivery with carbon nanotubes for in vivo cancer treatment. Cancer Res. 2008; 68(16): 6652-6660.
3. Yang K, Zhang S, Zhang G, Sun X, Lee ST, Liu Z. Graphene in mice: ultrahigh in vivo tumor uptake and efficient photothermal therapy. Nano Lett. 2010; 10(9): 3318-3323.
4. Hong H, Yang K, Zhang Y, et al. In vivo targeting and imaging of tumor vasculature with radiolabeled, antibody-conjugated nanographene. ACS Nano. 2012; 6(3): 2361-2370.
5. Chakravarty P, Marches R, Zimmerman NS, et al. Thermal ablation of tumor cells with antibody-functionalized single-walled carbon nanotubes. Proc Natl Acad Sci U S A. 2008; 105(25): 8697-8702.
6. Zhang M, Murakami T, Ajima K, et al. Fabrication of ZnPc/protein nanohorns for double photodynamic and hyperthermic cancer phototherapy. Proc Nat Acad Sci U S A. 2008; 105(39): 14773-14778.
7. Burke A, Ding X, Singh R, et al. Long-term survival following a single treatment of kidney tumors with multiwalled carbon nanotubes and near-infrared radiation. Proc Natl Acad Sci U S A. 2009; 106(31): 12897-12902.
8. Liu X, Tao H, Yang K, Zhang S, Lee ST, Liu Z. Optimization of surface chemistry on single-walled carbon nanotubes for in vivo photothermal ablation of tumors. Biomaterials. 2011; 32(1): 144-151.
9. Cherukuri P, Gannon CJ, Leeuw TK, et al. Mammalian pharmacokinetics of carbon nanotubes using intrinsic near-infrared fluorescence. Proc Natl Acad Sci U S A. 2006; 103(50): 18882-18886.
10. Hong G, Lee JC, Robinson JT, et al. Multifunctional in vivo vascular imaging using near-infrared II fluorescence. Nat Med. 2012; 18(12): 1841-1846.
11. Liu Z, Cai W, He L, et al. In vivo biodistribution and highly efficient tumour targeting of carbon nanotubes in mice. Nat Nanotechnol. 2007; 2(1): 47-52.
12. 3 labels. ACS Nano. 2009; 3(6): 1399-1406.
13. Qu G, Bai Y, Zhang Y, Jia Q, Zhang W, Yan B. The effect of multiwalled carbon nanotube agglomeration on their accumulation in and damage to organs in mice. Carbon. 2009; 47(8): 2060-2069.
14. Zhang S, Yang K, Feng L, Liu Z. In vitro and in vivo behaviors of dextran functionalized graphene. Carbon. 2011; 49(12): 4040-4049.
15. Tahara Y, Miyawaki J, Zhang M, et al. Histological assessments for toxicity and functionalization-dependent biodistribution of carbon nanohorns. Nanotechnology. 2011; 22(26): 265106.
16. Zhang M, Yamaguchi T, Iijima S, Yudasaka M. Size-dependent biodistribution of carbon nanohorns in vivo. Nanomedicine. 2013; 9(5): 657-664.
17. Singh R, Pantarotto D, Lacerda L, et al. Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotube radiotracers. Proc Natl Acad Sci U S A. 2006; 103(9): 3357-3362.
18. Matsumura Y, Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res. 1986; 46(12 Pt 1): 6387-6392.
19. Maeda H. The tumor blood vessel as an ideal target for macromolecular anticancer agents. J Control Release. 1992; 19(1-3): 315-324.
20. Smith BR, Kempen P, Bouley D, et al. Shape matters: intravital microscopy reveals surprising geometrical dependence for nanoparticles in tumor models of extravasation. Nano Lett. 2012; 12(7): 3369-3377.
21. Iijima S, Yudasaka M, Yamada R, et al. Nano-aggregates of singlewalled graphitic carbon nano-horns. Chem Phys Lett. 1999; 309(3-4): 165-170.
22. Azami T, Kasuya D, Yuge R, et al. Large-scale production of single-wall carbon nanohorns with high purity. The Journal of Physical Chemistry C. 2008; 112(5): 1330-1334.
23. 3 probes. The Journal of Physical Chemistry C. 2009; 113(7): 2741-2744.
24. Hadidi N, Kobarfard F, Nafissi-Varcheh N, Aboofazeli R. Optimization of single-walled carbon nanotube solubility by noncovalent PEGylation using experimental design methods. Int J Nanomedicine. 2011; 6: 737-746.
25. Yang M, Wada M, Zhang M, et al. A high poly(ethylene glycol) density on graphene nanomaterials reduces the detachment of lipidpoly(ethylene glycol) and macrophage uptake. Acta Biomater. 2013; 9(1): 4744-4753.
26. 2 laser ablation of graphite in Ne-gas atmosphere. Carbon. 2007; 45(6): 1364-1367.
27. Zhang M, Zhou X, Iijima S, Yudasaka M. Small-sized carbon nanohorns enabling cellular uptake control. Small. 2012; 8(16): 2524-2531.
28. De Palma M, Lewis CE. Cancer: Macrophages limit chemotherapy. Nature. 2011; 472(7343): 303-304.
29. Wynn TA, Chawla A, Pollard JW. Macrophage biology in development, homeostasis and disease. Nature. 2013; 496(7446): 445-455.
30. Shime H, Matsumoto M, Oshiumi H, et al. Toll-like receptor 3 signaling converts tumor-supporting myeloid cells to tumoricidal effectors. Proc Natl Acad Sci U S A. 2012; 109(6): 2066-2071.
31. Cieslewicz M, Tang J, Yu JL, et al. Targeted delivery of proapoptotic peptides to tumor-associated macrophages improves survival. Proc Natl Acad Sci U S A. 2013; 110(40): 15919-15924.